JPWO2007055355A1 - Multi-chamber container - Google Patents

Multi-chamber container Download PDF

Info

Publication number
JPWO2007055355A1
JPWO2007055355A1 JP2007544218A JP2007544218A JPWO2007055355A1 JP WO2007055355 A1 JPWO2007055355 A1 JP WO2007055355A1 JP 2007544218 A JP2007544218 A JP 2007544218A JP 2007544218 A JP2007544218 A JP 2007544218A JP WO2007055355 A1 JPWO2007055355 A1 JP WO2007055355A1
Authority
JP
Japan
Prior art keywords
storage bag
bag
medicine storage
discharge port
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544218A
Other languages
Japanese (ja)
Other versions
JP4962733B2 (en
Inventor
正治 伊吾田
正治 伊吾田
清水馨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2007544218A priority Critical patent/JP4962733B2/en
Publication of JPWO2007055355A1 publication Critical patent/JPWO2007055355A1/en
Application granted granted Critical
Publication of JP4962733B2 publication Critical patent/JP4962733B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2024Separating means having peelable seals

Abstract

薬剤収納袋10は軟弱合成樹脂フィルム状素材にて形成され、その内部空洞は弱シール部18により複数の隔室20, 22に区画され、その一つの隔室20に開口するように排出口12が設けられる。薬剤収納袋10の内部に小容積の封止袋13が配置され、封止袋13は薬剤収納袋10の内部空洞への排出口12の開口端を封止する。封止袋13を構成する合成樹脂フィルムは薬剤収納袋10を構成する合成樹脂フィルムのそれより脆弱な素材が選定される。薬剤収納袋10の内面と封止袋13の内面とは尖鋭なコーナー形状の矩形の小面積部分にて強固に溶着されている。弱シール部開通時の流体圧力による外部バッグの拡開により内部バッグは破裂開口せしめられる。The medicine storage bag 10 is formed of a soft synthetic resin film-like material, and its internal cavity is partitioned into a plurality of compartments 20 and 22 by a weak seal portion 18, and the discharge port 12 is opened so as to open into the one compartment 20. Is provided. A small-capacity sealing bag 13 is disposed inside the medicine storage bag 10, and the sealing bag 13 seals the open end of the discharge port 12 to the internal cavity of the medicine storage bag 10. As the synthetic resin film constituting the sealing bag 13, a material more fragile than that of the synthetic resin film constituting the medicine storage bag 10 is selected. The inner surface of the medicine storage bag 10 and the inner surface of the sealing bag 13 are firmly welded at a rectangular small area with a sharp corner shape. The inner bag is ruptured and opened by the expansion of the outer bag due to the fluid pressure when the weak seal portion is opened.

Description

本発明は、内部空洞が弱シール部によって分離されることにより、それぞれが別個に薬剤を封止収納する複数の隔室を形成し、使用時に弱シール部を開通させることで薬剤を混合し、排出させるようにした複室容器に関する。   In the present invention, the internal cavity is separated by the weak seal portion, thereby forming a plurality of compartments each separately containing and storing the drug, and the drug is mixed by opening the weak seal portion during use, The present invention relates to a multi-chamber container to be discharged.

点滴や透析などのための複室容器として多液混合型のものがある。複室容器においては、軟弱フィルムを素材とする薬剤収納袋の内部空洞は弱シール部によってそれぞれ異なった薬液を収容する複数の隔室に分離されている。薬剤収納袋の外周には、その形状を維持しうる剛性のあるプラスチック成型品としての薬液排出口が設けられ、薬液排出口は筒状に形成され、その内部空洞は一端側で一方の隔室に開口しているが、他端にはゴム栓が設けられている。患者への薬液の投与に先立って薬剤収納袋を外側から加圧することによって弱シール部が開通せしめられ、薬剤収納袋の内部空洞は一室となるため2種類の薬液は混合され、輸液セットの穿刺針によりゴム栓を穿刺し、薬剤収納袋よりの薬液の投与が可能となる。従って、この種の複室容器においては薬液の投与に先立って弱シール部の開通を行うことにより両液を混合せしめる作業は必須であり、他方、弱シール部の開通を行わないままで薬液排出口におけるゴム栓の穿刺を行うと、薬液排出口側の隔室における薬液のみが投与されてしまうという誤操作の可能性があった。この問題点に対処する従来技術として、薬剤収納袋の内部空洞を二つの隔室に分離する第1の弱シール部に加えて、薬液排出口の直前に第2の弱シール部を設け、第1の弱シール部の開通に要する圧力に対して第2の第2の弱シール部を同等若しくはそれ以上とすることにより、第1の弱シール部次いで第2の弱シール部の順序で開通されるようにし、これにより薬液の混合後に排出が行われるようにしたものが提案されている(特許文献1参照)。
特開平9−327498号公報
There are multi-liquid mixing type multi-chamber containers for infusion and dialysis. In a multi-chamber container, the internal cavity of a medicine storage bag made of a soft film is separated into a plurality of compartments for storing different chemical solutions by weak seal portions. On the outer periphery of the medicine storage bag, there is provided a chemical solution discharge port as a rigid plastic molded product capable of maintaining its shape, the chemical solution discharge port is formed in a cylindrical shape, and the internal cavity is one compartment on one end side The other end is provided with a rubber plug. Prior to administration of the drug solution to the patient, the weak seal portion is opened by pressurizing the drug storage bag from the outside, and the internal cavity of the drug storage bag becomes a single chamber, so the two types of drug solutions are mixed, and the infusion set A rubber stopper is punctured with a puncture needle, and a drug solution can be administered from a drug storage bag. Therefore, in this type of multi-chamber container, it is essential to open both of the weak seals by opening the weak seal prior to the administration of the chemicals, while on the other hand, the chemicals can be drained without opening the weak seals. When the rubber stopper was punctured at the outlet, there was a possibility of an erroneous operation in which only the drug solution in the compartment on the drug solution outlet side was administered. As a conventional technique for coping with this problem, in addition to the first weak seal portion that separates the internal cavity of the medicine storage bag into two compartments, a second weak seal portion is provided immediately before the chemical solution outlet, By making the second second weak seal portion equal to or higher than the pressure required to open the first weak seal portion, the first weak seal portion and then the second weak seal portion are opened in this order. Thus, there has been proposed a method in which discharge is performed after mixing of chemicals (see Patent Document 1).
JP-A-9-327498

特許文献1の技術は二つの隔室を分離する第1の弱シール部に加えて薬液排出口の直前に第2の弱シール部を設け、これらの弱シール部を順次開通させることで未混合のままの薬液の投与を防止しようとしているが、弱シール部を2個所設けているため、製造工程が複雑化し、また、強度の異なる複数の弱シールを精度よく製造することは非常に難度の高いものであり、コスト増となり、ユーザ側に2段階の加圧による開通作業を強いることになり、作業性としては必ずしも良くなかった。また、薬剤収納袋の加圧の仕方によっては第1の弱シール部→第2の弱シール部の順序によって必ずしも開通されるとは限らず、薬液排出口側の第2の弱シール部が先に開通されてしまうと、投与作業にそのまま移行してしまう可能性があり、この場合は未混合で1液のみ投与されてしまう結果となっていた。   In the technique of Patent Document 1, in addition to the first weak seal portion that separates the two compartments, a second weak seal portion is provided immediately before the chemical solution discharge port, and these weak seal portions are sequentially opened so that they are not mixed. However, since the two weak seals are provided, the manufacturing process is complicated, and it is very difficult to accurately manufacture a plurality of weak seals with different strengths. The cost is high, the cost is increased, and the user is forced to perform a two-stage pressurization work, which is not necessarily good workability. In addition, depending on the method of pressurizing the medicine storage bag, the opening is not always performed in the order of the first weak seal portion → the second weak seal portion, and the second weak seal portion on the side of the chemical solution discharge port is the first. If it is opened, there is a possibility of shifting to the administration work as it is, and in this case, only one solution is administered without mixing.

この発明は以上の問題点に鑑みてなされてものであり、未開通の状態では投与を行い得ない複室容器の新規な構造を提供し、製造コストが低廉でありかつユーザ側の作業性が良好であるにもかかわらず、未混合のままで投与が行われてしまうという誤操作の可能性をより確実に排除することを目的とする。   The present invention has been made in view of the above problems, and provides a novel structure of a multi-chamber container that cannot be administered in an unopened state, is low in manufacturing cost, and has a user-side workability. The object is to more surely eliminate the possibility of an erroneous operation in which administration is performed in an unmixed state despite being good.

この発明になる混合型薬剤封止袋状物は、可撓性フィルムにて形成された薬剤収納袋と、薬剤の排出のための排出口と、薬剤収納袋の内部空洞をそれぞれの薬剤の収納のための複数の隔室に分離し、薬剤収納袋に外部より印加される押圧力により開封され、それぞれの隔室に収納された薬剤の混合を行わしめる弱シール部とを備えている。薬剤収納袋を構成する可撓性フィルムより脆弱な可撓性フィルムにて形成され、薬剤収納袋の内部に位置する封止袋は、薬剤収納袋の内部空洞への薬剤収納袋の前記隔室への開口端を閉鎖するように排出口を包囲配置され、薬剤収納袋の内面は封止袋の対向外面と小面積部分にて溶着接合されて開封部を構成し、開封時の前記押圧力による薬剤収納袋の拡開により封止袋は前記開封部にて破壊せしめられて、排出口は薬剤収納袋の内部空洞に開口せしめられ、混合薬剤が排出口より排出される。開封部としては鋭角部とすることにより、応力集中を起こさせ、弱シール部開通により発生された流体圧力により封止袋を確実に破裂に至らしめることができる。   The mixed-type drug-sealed bag-like material according to the present invention has a drug storage bag formed of a flexible film, a discharge port for discharging the drug, and an internal cavity of the drug storage bag. And a weak seal portion that is opened by a pressing force applied from the outside to the medicine storage bag and mixes the medicines stored in the respective compartments. The sealing bag formed of a flexible film that is more fragile than the flexible film constituting the medicine storage bag and located inside the medicine storage bag is the compartment of the medicine storage bag into the internal cavity of the medicine storage bag. The outlet is surrounded and disposed so as to close the opening end of the medicine bag, and the inner surface of the medicine storage bag is welded and joined to the opposing outer surface of the sealing bag at a small area to form an opening portion, and the pressing force at the time of opening By opening the medicine storage bag by the above, the sealing bag is broken at the opening portion, the discharge port is opened in the internal cavity of the drug storage bag, and the mixed medicine is discharged from the discharge port. By making the opening portion an acute angle portion, stress concentration is caused, and the sealing bag can be surely ruptured by the fluid pressure generated by opening the weak seal portion.

排出口は薬剤収納袋の内部の封止袋により通常は閉鎖されており、封止袋は薬剤収納袋の対向面と小面積部分としての開封部にて強固に溶着接合されている。そのため、封止袋を構成する合成樹脂フィルムの材質や厚みや開封部の大きさや開封部の形状等を適宜選定することにより混合操作時の内部流体圧力により封止袋のみを確実に破壊せしめて、混合後の薬剤を排出口より排出させることができる。2液を混合すべき隔離シール(弱シール)と、混合薬剤の投与を防止する開封部を別の機構による開通構造とすることにより、確実な"段階的"連通を遂行させることができるものである。   The discharge port is normally closed by a sealing bag inside the medicine storage bag, and the sealing bag is firmly welded and joined to the opposite surface of the medicine storage bag at an opening portion as a small area portion. Therefore, by appropriately selecting the material and thickness of the synthetic resin film constituting the sealing bag, the size of the opening portion, the shape of the opening portion, etc., the internal fluid pressure during the mixing operation can reliably destroy only the sealing bag. The mixed drug can be discharged from the discharge port. By making the isolation seal (weak seal) with which the two liquids should be mixed and the opening part that prevents the administration of the mixed drug into an opening structure with a separate mechanism, it is possible to perform reliable "stepwise" communication. is there.

図1はこの発明の複室容器の平面図(図2のI方向矢視図)である。FIG. 1 is a plan view of the multi-chamber container of the present invention (viewed in the direction of arrow I in FIG. 2). 図2はこの発明の複室容器の断面図であり、図1のII−II線に沿って現される矢視図である。FIG. 2 is a sectional view of the multi-chamber container of the present invention, and is a view taken along the line II-II in FIG. 図3は図2における排出口付近の部分図であり、この発明の複室容器の開封時の状態を模式的に示している。FIG. 3 is a partial view of the vicinity of the discharge port in FIG. 2, and schematically shows a state when the multi-chamber container of the present invention is opened. 図4はポイントシール方法の一例を一連の工程にて示す概略図である。FIG. 4 is a schematic view showing an example of the point seal method in a series of steps. 図5は図4はポイントシール方法の別の一例を一連の工程にて示す概略図である。FIG. 5 is a schematic view showing another example of the point seal method in a series of steps. 図6はポイントシール支持板を具備した内部バッグ装着済の排出口を示す。FIG. 6 shows a discharge port with an internal bag mounted with a point seal support plate. 図7は図6において、排出口に対するポイントシール支持板の装着状態を模式的に示す斜視図である。FIG. 7 is a perspective view schematically showing a state where the point seal support plate is attached to the discharge port in FIG. 図8は、ポイントシールに加えて、薬剤収納袋10と内側バッグ13の対向面を実質的全幅のヒートシール部にて接続した別実施形態における複室容器の排出口付近の部分図である。FIG. 8 is a partial view of the vicinity of the discharge port of the multi-chamber container in another embodiment in which the opposing surfaces of the medicine storage bag 10 and the inner bag 13 are connected by a heat seal part of substantially full width in addition to the point seal.

符号の説明Explanation of symbols

10…薬剤収納袋
12…排出口
13…封止袋
18…弱シール部
20, 22…隔室
30…小面積部分(ポイントシール)
50…ポイントシール具受板
10 ... Drug storage bag 12 ... Discharge port 13 ... Sealing bag 18 ... Weak seal part
20, 22 ... compartment 30 ... small area (point seal)
50 ... Point seal plate

図1〜図2において、複室容器は薬剤の収納のための平坦状の薬剤収納袋(外部バッグ)10と、薬剤収納袋10の外周部に固定される排出口12と、薬剤収納袋10の内部空洞に対して排出口12を通常状態において封止する小容積の封止袋(内部バッグ)13とから構成される。薬剤収納袋10は厚さ200ミクロンといったポリプロピレンフィルムやポリエチレンフィルムなどの多層構造の軟弱フィルム(本発明の可撓性素材)を素材とする。2枚の合成樹脂フィルム切片はその外周にてその軟化温度より十分高い高温(ポリプロピレンの場合は120℃)にて加圧されることにより形成された強シール部14により封止され、実質的に矩形の袋状をなしている。この薬剤収納袋10は、上記のようなフィルムからの製袋によるものの他に、チューブ状インフレーションフィルムからの製袋や、ブロー成形による容器とすることもできる。強シール部14には懸垂孔16が穿設され、この懸垂孔16によって薬剤収納袋10を点滴台などに吊り下げ保持し、点滴や透析作業を行うことになる。   1 to 2, the multi-chamber container includes a flat medicine storage bag (external bag) 10 for storing medicine, a discharge port 12 fixed to the outer periphery of the medicine storage bag 10, and a medicine storage bag 10. And a small-capacity sealing bag (inner bag) 13 that seals the outlet 12 in a normal state. The medicine storage bag 10 is made of a soft film (flexible material of the present invention) having a multilayer structure such as a polypropylene film or a polyethylene film having a thickness of 200 microns. The two pieces of synthetic resin film are sealed at the outer periphery by a strong seal portion 14 formed by being pressed at a high temperature (120 ° C. in the case of polypropylene) sufficiently higher than the softening temperature. It has a rectangular bag shape. The medicine storage bag 10 may be a bag made from a tubular inflation film or a container formed by blow molding, in addition to the bag made from the film as described above. A suspension hole 16 is formed in the strong seal portion 14, and the medicine storage bag 10 is suspended and held by the suspension hole 16 on an infusion stand or the like to perform infusion or dialysis.

薬剤収納袋10の長さ方向における中間部位において全幅にわたって弱シール部(剥離可能溶着部)18が延びており、弱シール部18によって薬剤収納袋10の表裏対抗内面が溶着され、薬剤収納袋10の内部空洞は第1隔室20と第2隔室22とに区画される。第1隔室20に第1薬液が充填され、第2隔室22に第2薬液が充填される。弱シール部18は薬剤収納袋10を形成する合成樹脂フィルム切片の表裏面をその軟化温度よりやや高い低温(ポリプロピレンの場合は110℃)加圧することにより形成される。そのため、第1隔室20と第2隔室22にそれぞれの薬液を収容した状態で隔室20, 22の部位において薬剤収納袋10における薬液を外側より加圧することにより、強シール部14はそのままに、弱シール部18を流体圧(加圧時の薬液の圧力)にて破壊・開通せしめ、第1薬液と第2薬液との混合を行うことができる。   A weak seal portion (peelable weld portion) 18 extends over the entire width of the intermediate portion in the length direction of the medicine storage bag 10, and the front and back opposing inner surfaces of the medicine storage bag 10 are welded by the weak seal portion 18. The internal cavity is divided into a first compartment 20 and a second compartment 22. The first compartment 20 is filled with the first chemical solution, and the second compartment 22 is filled with the second chemical solution. The weak seal portion 18 is formed by pressurizing the front and back surfaces of the synthetic resin film section forming the medicine storage bag 10 at a low temperature (110 ° C. in the case of polypropylene) slightly higher than its softening temperature. Therefore, the strong seal portion 14 is left as it is by pressurizing the drug solution in the drug storage bag 10 from the outside in the compartments 20 and 22 with the respective drug solutions stored in the first compartment 20 and the second compartment 22. In addition, the weak seal portion 18 can be broken and opened by fluid pressure (pressure of the chemical at the time of pressurization) to mix the first chemical and the second chemical.

排出口12は、その形態を維持しうる剛性を有した肉厚を有した合成樹脂(薬剤収納袋10との密着性を得るため薬剤収納袋10と同一プラスチック素材とするのが好ましい)の成形品である。排出口12は両端で開口し、中間がテーパ部12-1をなし、上端にフランジ部12-2(図1)を有した筒状に形成される。フランジ部12-2にはキャップ12-3が突当溶着され、キャップ12-3の底面開口部にはゴム製内蓋12-4(本発明の栓体)が装着される。点滴などの輸液時には輸液セットの穿刺針により内蓋12-4を穿刺し、薬剤収納袋10の内部空洞を輸液チューブに連通させ、輸液を行うことになる。この実施形態においては、薬剤収納袋10の表裏面を形成する合成樹脂フィルムは封止袋13の表裏面を形成する合成樹脂フィルムを介して排出口12の筒状部を上下より挟みつつ加熱密着され、これにより排出口12に対する薬剤収納袋10の封止が行われている。   The discharge port 12 is formed of a synthetic resin having a thickness and rigidity capable of maintaining the form (preferably made of the same plastic material as the drug storage bag 10 in order to obtain adhesion to the drug storage bag 10). It is a product. The discharge port 12 is open at both ends, and is formed in a cylindrical shape having a tapered portion 12-1 at the middle and a flange portion 12-2 (FIG. 1) at the upper end. A cap 12-3 is abutted and welded to the flange portion 12-2, and a rubber inner lid 12-4 (a plug of the present invention) is attached to the bottom opening of the cap 12-3. At the time of infusion such as infusion, the inner lid 12-4 is punctured by the puncture needle of the infusion set, and the inner cavity of the medicine storage bag 10 is communicated with the infusion tube to perform infusion. In this embodiment, the synthetic resin film forming the front and back surfaces of the medicine storage bag 10 is heated and adhered while sandwiching the cylindrical portion of the discharge port 12 from above and below via the synthetic resin film forming the front and back surfaces of the sealing bag 13. Thus, the medicine storage bag 10 is sealed with respect to the discharge port 12.

図1及び2に示すように、小容積の封止袋13は薬剤収納袋10の内部に設けられ、排出口12を通常時において封止するため設けられる。封止袋13は薬剤収納袋10と同様にポリプロピレンフィルムやポリエチレンフィルムのような上下の2枚の合成樹脂フィルム切片を外周部13Aにて高温(薬剤収納袋10の強シール部14の溶着温度と同等の温度)にて溶着することにより形成されるが、後述のように、弱シール18の開封時の流体圧力による薬剤収納袋10の拡開によってポイントシール部で破裂せしめられるように、封止袋13を構成する合成樹脂フィルムは強度的には薬剤収納袋10を構成する合成樹脂フィルムより適当に脆弱とされている。他方、ポイントシール時の熱圧着性からみると内外のバッグは素材としては同一の合成樹脂素材であるのが好ましく、所望の強度差を持たせるため封止袋13を構成する合成樹脂フィルムの厚みを、薬剤収納袋10を構成する合成樹脂フィルムのそれより適当に薄くすることができる。または、薬剤収納袋10を構成する合成樹脂の重合度を封止袋13を構成する合成樹脂の重合度より小さくしたり、コーポリマーとするなどの手段により内外のバッグ間で必要な強度差を持たせるようにすることができる。また、封止袋13には、点滴速度に比して非常に遅い流速の液体が通過できるような微小な孔を穿設することによる封止袋13内の湿熱下の減菌(無菌化)操作に有利である。このため、ポイントシール部をミシン目状とすることにより、ポイントシール時に同時に穿孔することもできる。尚、図2ではバッグ10, 13は相当な厚みを持たせて描いているが、これは作図の便宜上であって、厚みについては相当に誇張して描かれている点に留意されたい。   As shown in FIGS. 1 and 2, the small-capacity sealing bag 13 is provided inside the medicine storage bag 10 and is provided to seal the discharge port 12 in a normal state. The sealing bag 13 is similar to the medicine storage bag 10 in that the two upper and lower synthetic resin film sections such as polypropylene film and polyethylene film are heated at the outer peripheral portion 13A (the welding temperature of the strong seal portion 14 of the medicine storage bag 10). It is formed by welding at the same temperature), but as described later, it is sealed so that it can be ruptured at the point seal portion by opening the medicine storage bag 10 due to fluid pressure when the weak seal 18 is opened. The synthetic resin film constituting the bag 13 is suitably weaker than the synthetic resin film constituting the drug storage bag 10 in terms of strength. On the other hand, from the viewpoint of thermocompression bonding at the time of point sealing, the inner and outer bags are preferably made of the same synthetic resin material, and the thickness of the synthetic resin film constituting the sealing bag 13 in order to have a desired difference in strength. Can be appropriately made thinner than that of the synthetic resin film constituting the medicine storage bag 10. Alternatively, the required strength difference between the inner and outer bags can be reduced by means such as making the polymerization degree of the synthetic resin constituting the medicine storage bag 10 smaller than the polymerization degree of the synthetic resin constituting the sealing bag 13 or using a copolymer. It can be made to have. In addition, the sealing bag 13 is sterilized under sterilization (humidification) in the sealing bag 13 by making a minute hole through which a liquid having a flow rate very slow compared to the drip rate can pass. It is advantageous for operation. For this reason, by making the point seal portion into a perforated shape, it is possible to drill at the same time as the point seal. In FIG. 2, the bags 10 and 13 are drawn with a considerable thickness. However, this is for the convenience of drawing, and it should be noted that the thickness is drawn with a considerable exaggeration.

封止袋13は、図1に示すように、排出口12の外径より幾分大きな幅を持ち、薬剤収納袋10の内部空洞に向けて延びており、薬剤収納袋10の未開通時(弱シール部18により隔室20, 22が分離状態時)に、薬剤収納袋10の内部空洞に対して排出口12を閉鎖することにより、薬液が未混合で排出口12より排出されるのを阻止する。そして、隔室20, 22の薬剤の混合のため弱シール部18を開口させるべく薬剤収納袋10を、なるべくは排出口12から離間側の隔室20において加圧したときに薬剤収納袋10の内部に生ずる衝撃的薬液流(図3の矢印F)による薬剤収納袋10の拡開により封止袋13の破断が惹起せしめられ、薬剤を収納した薬剤収納袋10の内部空洞が排出口12に連通せしめられ、排出口12からの混合薬液の排出が可能となる。そして、この実施形態においては、後述のように封止袋13は薬剤収納袋10と共に排出口12に取り付けられている。即ち、薬剤収納袋10の外周における強シール部14は部分14-1において排出口12の外周に溶着されているが、この溶着時に封止袋13の外周部13-1も重ねて溶着されるようになっている(図2参照)。他方、封止袋13は薬剤収納袋10の内部空洞(隔室22)に対しては通常は、即ち、弱シール部18の未開通時、閉鎖されることにより薬剤収納袋10内の薬剤が排出口12に向かうのを阻止している。そして、封止袋13はその外面が薬剤収納袋10の対向内面(上下内面)に小面積部分30にて溶着(ポイントシール)されている。封止袋13の外面を薬剤収納袋10の対向内面に溶着するこの小面積部分30は図1の斜線領域として示すように尖鋭なコーナー部を有した矩形形状をなしており、溶着温度としては薬剤収納袋10の外周の強シール部14の溶着温度と同等の高温度である。弱シール部18の開封時に、薬剤収納袋10は拡開され、外面が薬剤収納袋10の対向内面に小面積部分30にて溶着されている封止袋13は上下に引張力を受け、小面積部分30の溶着が強固であるため、封止袋13には引き裂き力が発生し、封止袋13を構成する合成樹脂フィルムは薬剤収納袋10を構成する合成樹脂フィルムより強度的に弱くかつ小面積部分30の尖鋭形状によって生ずる応力集中の効果もあって、薬剤収納袋10の拡開によって封止袋13はポイントシール部分30で強く引っ張られ、図3に示すように封止袋13はポイントシール部分30で破裂せしめられ、排出口12が開通され、薬液の排出が可能となる。即ち、薬剤収納袋10の開通のため薬剤収納袋10は机などの上に図2のように平坦に載置され、薬剤収納袋10は上面より手のひらで矢印bのように加圧される(図3に示すように隔室20側において薬剤収納袋10を加圧するのが好ましいが隔室22の側を加圧しても両側を加圧してもよい)。薬剤収納袋10の加圧により弱シール部18に液圧が加わり、所定の圧力により弱シール部18は瞬時に破壊開通するに至る。加圧により薬剤収納袋10の内圧は高められており、弱シール部18の開通の開通によりこの高められた圧力が一気に放出されるため、衝撃的な薬液の流れが薬剤収納袋10内に惹起される。薬剤収納袋10内に惹起された衝撃的な薬液の流れを図3では矢印Fにより模式的に示す。弱シール部18の開通の際に薬剤収納袋10内に惹起された急激な薬液の流れFは薬剤収納袋10を図3に示すように大きく拡開させる。そのため、薬剤収納袋10の対向面に小面積部分30にて強固に溶着された小容積の封止袋13には大きな引き裂き力が生じせしめられ、封止袋13を構成する合成樹脂フィルムは薬剤収納袋10を構成する合成樹脂フィルムより引裂き強度が弱いことから破裂に至らしめることができる。図3では封止袋30のポイントシール部分が13´のように薬剤収納袋10に溶着されたまま引き裂かれ、その結果封止袋13に開口40が形成され、薬剤が矢印のように開口40を介して排出口12に向けて流通可能となった状態を示しており、この状態において、ゴム栓12-3を図示しない輸液セットの穿刺針により穿刺することにより混合薬液の排出が可能となる。このように、本発明では2液を混合すべき隔離シール(弱シール18)の開通と、混合薬剤の投与を防止する開封部(ポイントシール30)の開通とが別の機構による言わば"段階的"開通構造されているため、開通作業時の確実な連通動作を実現させることができる。   As shown in FIG. 1, the sealing bag 13 has a width slightly larger than the outer diameter of the discharge port 12, extends toward the internal cavity of the medicine storage bag 10, and when the medicine storage bag 10 is not opened ( When the discharge port 12 is closed with respect to the internal cavity of the drug storage bag 10 when the compartments 20 and 22 are separated by the weak seal portion 18, the drug solution is discharged from the discharge port 12 without being mixed. Stop. When the medicine storage bag 10 is pressed to open the weak seal portion 18 for mixing medicines in the compartments 20 and 22, and preferably in the compartment 20 on the side away from the discharge port 12, the medicine storage bag 10 The opening of the medicine storage bag 10 due to the shocking chemical liquid flow (arrow F in FIG. 3) generated inside causes the sealing bag 13 to break, and the internal cavity of the medicine storage bag 10 storing the medicine is at the discharge port 12. The communication is made possible, and the mixed chemical solution can be discharged from the discharge port 12. In this embodiment, the sealing bag 13 is attached to the discharge port 12 together with the medicine storage bag 10 as described later. That is, the strong seal portion 14 on the outer periphery of the medicine storage bag 10 is welded to the outer periphery of the discharge port 12 at the portion 14-1, but the outer peripheral portion 13-1 of the sealing bag 13 is also overlapped and welded at the time of this welding. (See FIG. 2). On the other hand, the sealing bag 13 is normally closed with respect to the internal cavity (compartment 22) of the medicine storage bag 10, that is, when the weak seal portion 18 is not opened, the medicine in the medicine storage bag 10 is closed. Blocking toward the outlet 12. The outer surface of the sealing bag 13 is welded (point-sealed) to the opposing inner surface (upper and lower inner surfaces) of the medicine storage bag 10 with a small area portion 30. This small area portion 30 that welds the outer surface of the sealing bag 13 to the opposite inner surface of the medicine storage bag 10 has a rectangular shape with sharp corners as shown by the hatched area in FIG. The high temperature is equivalent to the welding temperature of the strong seal portion 14 on the outer periphery of the medicine storage bag 10. When the weak seal portion 18 is opened, the medicine storage bag 10 is expanded, and the sealing bag 13 whose outer surface is welded to the opposite inner surface of the medicine storage bag 10 with a small area portion 30 receives a tensile force in the vertical direction and is small. Since the welding of the area portion 30 is strong, a tearing force is generated in the sealing bag 13, and the synthetic resin film constituting the sealing bag 13 is weaker than the synthetic resin film constituting the drug storage bag 10 and There is also an effect of stress concentration caused by the sharp shape of the small area portion 30, the sealing bag 13 is strongly pulled by the point seal portion 30 by the expansion of the medicine storage bag 10, and the sealing bag 13 is The point seal portion 30 is ruptured, the discharge port 12 is opened, and the chemical solution can be discharged. That is, in order to open the medicine storage bag 10, the medicine storage bag 10 is placed flat on a desk or the like as shown in FIG. 2, and the medicine storage bag 10 is pressurized with a palm from the top as shown by an arrow b ( As shown in FIG. 3, it is preferable to pressurize the medicine storage bag 10 on the side of the compartment 20, but the side of the compartment 22 may be pressurized or both sides may be pressurized). The liquid pressure is applied to the weak seal portion 18 by pressurization of the medicine storage bag 10, and the weak seal portion 18 is instantaneously broken and opened by a predetermined pressure. The internal pressure of the medicine storage bag 10 is increased by the pressurization, and this increased pressure is released at once by opening and closing the weak seal portion 18, so a shocking flow of the chemical solution is caused in the medicine storage bag 10. Is done. In FIG. 3, the shocking flow of the chemical liquid that is caused in the medicine storage bag 10 is schematically indicated by an arrow F. The rapid flow F of the drug solution induced in the medicine storage bag 10 when the weak seal portion 18 is opened causes the medicine storage bag 10 to greatly expand as shown in FIG. Therefore, a large tearing force is generated in the small-capacity sealing bag 13 firmly welded to the opposite surface of the medicine storage bag 10 by the small area portion 30, and the synthetic resin film constituting the sealing bag 13 is a drug. Since the tear strength is weaker than that of the synthetic resin film constituting the storage bag 10, it can be ruptured. In FIG. 3, the point seal portion of the sealing bag 30 is torn while being welded to the medicine storage bag 10 as indicated by 13 ′. As a result, an opening 40 is formed in the sealing bag 13, and the medicine is opened as indicated by an arrow 40. In this state, the mixture can be discharged by puncturing the rubber plug 12-3 with a puncture needle of an infusion set (not shown). . In this way, in the present invention, the opening of the isolation seal (weak seal 18) to be mixed with the two liquids and the opening of the opening portion (point seal 30) for preventing the administration of the mixed medicine are said to be “stepwise”. "Because of the opening structure, it is possible to achieve reliable communication during opening work.

小面積部分30の鋭角の矩形形状は応力集中効果によって封止袋13の破裂をより確実に惹起せしめることに寄与させることができる。そして、封止袋13を構成する合成樹脂フィルムの組成や肉厚等を最適設定することで、薬剤収納袋の未開通時(弱シール部18の閉鎖時)における排出口12への薬剤の流入阻止(封止袋13による排出口12の閉鎖状態の維持)を確実に行いつつ、薬剤収納袋の開通時(弱シール部18の開通時)における内部バック13の確実な破裂による薬剤の排出が可能となるようにすることができる。   The acute rectangular shape of the small area portion 30 can contribute to more reliably causing the sealing bag 13 to rupture due to the stress concentration effect. Then, by optimally setting the composition and thickness of the synthetic resin film constituting the sealing bag 13, the inflow of the drug into the discharge port 12 when the drug storage bag is not opened (when the weak seal portion 18 is closed) While reliably preventing (maintaining the closed state of the discharge port 12 by the sealing bag 13), the medicine is discharged by the reliable rupture of the inner bag 13 when the medicine storage bag is opened (when the weak seal portion 18 is opened). Can be made possible.

薬剤収納袋10の封止によるこの発明の複室容器の形成工程の一例について図4により説明すると、薬剤収納袋10を形成する上下合成樹脂フィルムは(a)のように外周の強シール部14が部位14Aにおいて未溶着であり、この未溶着部位で開口部を呈している。封止袋13は薬剤収納袋10の内部に既に収容されており、外周部13Aは排出口12の装着部位13Bに開口を残して外部バッグの開口部位14Aの内側に仮溶着されている。   An example of the process of forming the multi-chamber container of the present invention by sealing the medicine storage bag 10 will be described with reference to FIG. 4. The upper and lower synthetic resin films forming the medicine storage bag 10 are the strong sealing portions 14 on the outer periphery as shown in FIG. Is not welded at the site 14A, and an opening is present at this site. The sealing bag 13 is already accommodated in the medicine storage bag 10, and the outer peripheral portion 13A is temporarily welded to the inside of the opening portion 14A of the external bag leaving an opening in the mounting portion 13B of the discharge port 12.

次に、封止袋13の未封止開口部13Bに向けて溶着具の受具が挿入され、外部の溶着具との間でポイントシールが行われる。即ち、ポイントシール部の形状に準じた溶着部形状を有する溶着具と受具とは薬剤収納袋10を構成するフィルム切片及び封止袋13を構成するフィルム切片を介して当接せしめられ、薬剤収納袋10の内面と封止袋13の外面との間のポイントシール(小面積部分30での高温溶着)が行われる。   Next, a receiving tool for the welding tool is inserted toward the unsealed opening 13B of the sealing bag 13, and point sealing is performed with the external welding tool. That is, the welding tool having a welded part shape conforming to the shape of the point seal part and the receiver are brought into contact with each other via the film slice constituting the medicine storage bag 10 and the film slice constituting the sealing bag 13. Point sealing (high temperature welding at the small area portion 30) between the inner surface of the storage bag 10 and the outer surface of the sealing bag 13 is performed.

そして、排出口12が(b)の矢印fのように封止袋13の未溶着開口部に向けて挿入され、薬剤収納袋10の外側より溶着が行われる。そのため、薬剤収納袋10を構成する合成樹脂フィルム切片の未封止部14Aは封止袋13を構成する合成樹脂フィルムの未封止部を介して排出口12の外周に対して加熱圧着され、封止袋10は封止袋13を介して排出口12に対して溶着される。   Then, the discharge port 12 is inserted toward the unwelded opening of the sealing bag 13 as indicated by the arrow f in (b), and welding is performed from the outside of the medicine storage bag 10. Therefore, the unsealed portion 14A of the synthetic resin film section constituting the medicine storage bag 10 is thermocompression bonded to the outer periphery of the discharge port 12 through the unsealed portion of the synthetic resin film constituting the sealing bag 13, The sealing bag 10 is welded to the discharge port 12 via the sealing bag 13.

(c)は排出口12の溶着後の状態を示し、この状態において図1の弱シール部18の溶着形成並びにその後の隔室20, 22への薬剤充填及び充填口のシールが行われ、この発明の複室容器が完成する。   (C) shows a state after the discharge port 12 is welded. In this state, the weak seal portion 18 shown in FIG. 1 is welded and the compartments 20 and 22 are filled with chemicals and the filling port is sealed. The multi-chamber container of the invention is completed.

図5は別実施形態のポイントシール方法を示しており、(a)に示すように排出口12として、封止袋13を溶着済みのものを先に準備する。薬剤収納袋10は外周の強シール部14に未溶着部14Aを残しており、この未溶着部分が開口部をなしており、この未シールの開口部を介して封止袋13を薬剤収納袋10に挿入する(図5(b))。そして、排出口12に対して未溶着部14Bの溶着が行われ、全周での強シール部14が完成する。そして、(c)で示すようにポイントシールが行われ、薬剤収納袋10と封止袋13とは対向面における矩形の小面積部分30にて溶着される。この場合のポイントシールは薬剤収納袋10及びその内側の封止袋13を外側より挟むように溶着具を配置し、溶着具を内外のバッグを介して圧着することで、薬剤収納袋10の内面と薬剤収納袋10の外面とを小面積にて溶着するように行われる。   FIG. 5 shows a point seal method according to another embodiment. As shown in FIG. 5A, a discharge bag 12 having a sealed bag 13 already welded is prepared first. The medicine storage bag 10 has an unwelded portion 14A left on the outer peripheral strong seal portion 14, and this unwelded portion forms an opening, and the sealing bag 13 is connected to the medicine storage bag through the unsealed opening. 10 (FIG. 5B). And the unwelded part 14B is welded with respect to the discharge port 12, and the strong seal part 14 in the perimeter is completed. Then, as shown in (c), point sealing is performed, and the medicine storage bag 10 and the sealing bag 13 are welded at a rectangular small area portion 30 on the opposing surface. In this case, the point seal is such that the welding tool is disposed so as to sandwich the medicine storage bag 10 and the inner sealing bag 13 from the outside, and the welding tool is pressure-bonded via the inner and outer bags, thereby the inner surface of the medicine storage bag 10. And the outer surface of the medicine storage bag 10 are welded in a small area.

図5の実施形態におけるポイントシールの溶着性の改善を図るため排出口12として、図6に示すように封止袋13の内部空洞に突出するポイントシール具受板50を備えたものを使用することができる。ポイントシール具受板50は図7に示すように、排出口12の内径より幾分広い基板部50-1と、基板部50-1に直交する受板部50-2とを備え、基板部50-1は排出口12の内径部分に直径対立位置に形成された溝部52に圧嵌固定せしめられる。ポイントシール具受板50内外のバッグを構成する合成樹脂フィルムに対して溶着しにくい材質とする。ポイントシールは薬剤収納袋10及び内側バッグ13を受板部50-2を介して外側より溶着具により挟むように行われる。そのため、薬剤収納袋10の内面と内封止袋13の外面との対向面間で小面積部分でのポイントシールを効率的に行うことができ、空隙が残るため薬剤の流路を十分確保することができる。   In order to improve the weldability of the point seal in the embodiment of FIG. 5, the discharge port 12 having a point seal receiving plate 50 protruding into the internal cavity of the sealing bag 13 as shown in FIG. 6 is used. be able to. As shown in FIG. 7, the point seal tool receiving plate 50 includes a substrate portion 50-1 somewhat wider than the inner diameter of the discharge port 12 and a receiving plate portion 50-2 orthogonal to the substrate portion 50-1. 50-1 is press-fitted and fixed to a groove 52 formed at a diameter-opposing position on the inner diameter portion of the discharge port 12. The point seal device receiving plate 50 is made of a material that hardly adheres to the synthetic resin film constituting the bag inside and outside. The point seal is performed so that the medicine storage bag 10 and the inner bag 13 are sandwiched by the welding tool from the outside via the receiving plate portion 50-2. Therefore, it is possible to efficiently perform point sealing in a small area portion between the opposed surfaces of the inner surface of the medicine storage bag 10 and the outer surface of the inner sealing bag 13, and a sufficient flow path for the medicine is ensured because a gap remains. be able to.

以上説明の実施形態では薬剤収納袋10と内側バッグ13との対向面はポイントシールのみで接結されているが、図8に示すようにポイントシール30に加え、排出口12に近い部位における内側バッグ13の実質的全幅のヒートシール部(高温溶着部=本発明の付加的シール部)42により薬剤収納袋10と内側バッグ13との対向面間を接結することができる。ヒートシール部42は幅広になっているため、ポイントシール30程強い応力集中は生じない。そのため、弱シール部の開通時の急激な薬液の流れによる薬剤収納袋10の拡開時にポイントシール30の部分で内側バッグ13は破れても、ヒートシール部42は破れない若しくは破れ難いため、内側バッグ13は全体としては薬剤収納袋10に接合されたままで、すなわち、膨らんだ袋形状を維持し、ポイントシール30の部分のみ開口せしめられるため、薬剤収納袋10の内部空洞からポイントシール30が破れてできた開口部を介して内側バッグ13を経て排出口12に向けてのスムースな薬液の流れを確保することができる。   In the embodiment described above, the opposing surfaces of the medicine storage bag 10 and the inner bag 13 are connected only by the point seal, but as shown in FIG. The opposing surfaces of the medicine storage bag 10 and the inner bag 13 can be connected by a heat seal portion (high temperature weld portion = additional seal portion of the present invention) 42 of substantially the full width of the bag 13. Since the heat seal part 42 is wide, stress concentration as strong as the point seal 30 does not occur. Therefore, even if the inner bag 13 is torn at the portion of the point seal 30 when the medicine storage bag 10 is expanded due to the rapid flow of the chemical solution when the weak seal portion is opened, the heat seal portion 42 is not torn or hardly torn. Since the bag 13 remains joined to the medicine storage bag 10 as a whole, that is, the bag 13 is maintained in an inflated bag shape and only the portion of the point seal 30 is opened, the point seal 30 is broken from the internal cavity of the medicine storage bag 10. A smooth flow of the chemical liquid toward the discharge port 12 through the inner bag 13 can be ensured through the opening formed in this way.

また、図2に関連して説明したように薬剤収納袋10と内側バッグ13とは上下両側の対向面で一対のポイントシール30により接合されていたが、薬剤収納袋10と内側バッグ13の対向面を接合するポイントシール30は図2の上側及び下側のうちの一方の対向面のみに設け、他方の対向面は応力集中が生じにくい実質的に全幅に亘るヒートシール部にて接合するようにしてもよい。この場合においては、薬剤混合のため弱シールの開通時の薬剤収納袋10の拡開は片側のポイントシールのみ破裂開口させ、他方のヒートシール部は破裂されず、薬剤収納袋10と内側バッグ13の対向面は接合のままであるため、図8と同様に内側バッグ13が潰れ難いため、ポイントシールの部位での破れにより形成された開口部を介してのスムースな薬液の流れも同様に確保することができる。   In addition, as described with reference to FIG. 2, the medicine storage bag 10 and the inner bag 13 are joined by the pair of point seals 30 on the opposing surfaces on the upper and lower sides, but the medicine storage bag 10 and the inner bag 13 are opposed to each other. The point seal 30 that joins the surfaces is provided only on one of the upper and lower surfaces in FIG. 2, and the other facing surface is joined at a heat seal portion that covers substantially the entire width where stress concentration is unlikely to occur. It may be. In this case, when the weak seal is opened for drug mixing, the drug storage bag 10 is opened only by rupturing and opening only the point seal on one side, and the other heat seal part is not ruptured, and the drug storage bag 10 and the inner bag 13 are opened. Since the opposite surface remains bonded, the inner bag 13 is not easily crushed similarly to FIG. 8, so that a smooth flow of the chemical liquid through the opening formed by the tear at the point seal portion is ensured as well. can do.

Claims (5)

可撓性フィルムにて形成された薬剤収納袋と、薬剤の排出のため薬剤収納袋に装着された排出口と、薬剤収納袋内部をそれぞれの薬剤の収納のための複数の隔室に分離し、それぞれの隔室に収納された薬剤の混合のため薬剤収納袋に外部より印加される押圧力により剥離開通されるように薬剤収納袋の対向内面を溶着する弱シール部と、薬剤収納袋を構成する可撓性フィルムより脆弱な可撓性フィルムにて形成され、薬剤収納袋の内部に位置して薬剤収納袋内部への排出口の開口端を包囲閉鎖する封止袋と、薬剤収納袋と封止袋との対向面と小面積領域にて溶着接合してなる開封部とを備え、開封時の前記押圧力による薬剤収納袋の拡開により封止袋は前記開封部にて破壊せしめられて、排出口を薬剤収納袋内部空洞に連通する開口部が封止袋に形成される複室容器。   A medicine storage bag formed of a flexible film, a discharge port attached to the medicine storage bag for discharging the medicine, and the inside of the medicine storage bag are divided into a plurality of compartments for storing each medicine. A weak seal portion that welds the opposite inner surfaces of the drug storage bag so that the drug storage bag is peeled open by a pressing force applied from the outside to mix the drugs stored in the respective compartments, and a drug storage bag A sealing bag that is formed of a flexible film that is more fragile than the flexible film that is configured, and that surrounds and closes the opening end of the discharge port into the medicine storage bag, and is located inside the medicine storage bag; And an opening part formed by welding and bonding in a small area, and the sealing bag is broken at the opening part by opening the medicine storage bag by the pressing force at the time of opening. The opening that communicates the discharge port with the cavity inside the drug storage bag is sealed Multiple chambers formed. 請求項1に記載の発明において、前記開封部は鋭角部を有する形状をなしている複室容器。   The multi-chamber container according to claim 1, wherein the opening portion has a shape having an acute angle portion. 請求項1若しくは2に記載の発明において、排出口は開封部に正対するべく封止袋の内部に延出する溶着具受板を備えた複室容器。   3. The multi-chamber container according to claim 1 or 2, wherein the discharge port includes a welder receiving plate that extends into the sealing bag so as to face the opening portion. 請求項1から請求項3のいずれか一項に記載の発明において、前記開封部に加えて、薬剤収納袋と封止袋との対向面間を溶着接合する付加的シール部を備え、前記付加的シール部は、封止袋の破壊時に封止袋の拡開形状を維持する複室容器。   The invention according to any one of claims 1 to 3, further comprising an additional seal portion that welds and joins the facing surfaces of the medicine storage bag and the sealing bag in addition to the opening portion. The target seal portion is a multi-chamber container that maintains the expanded shape of the sealing bag when the sealing bag is broken. 可撓性フィルムにて形成された薬剤収納袋と、薬剤の排出のため薬剤収納袋に装着された排出口と、排出口に設けられた栓体と、薬剤収納袋内部をそれぞれの薬剤の収納のための複数の隔室に分離し、それぞれの隔室に収納された薬剤の混合のため薬剤収納袋に外部より印加される押圧力により剥離開通されるように薬剤収納袋の対向内面を溶着する弱シール部とを備えた複室容器により輸液作業を行う方法であって、前記排出口に、薬剤収納袋を構成する可撓性フィルムより脆弱な可撓性フィルムにて形成され、薬剤収納袋の内部に位置して薬剤収納袋内部への排出口の開口端を包囲閉鎖する封止袋を設け、更に薬剤収納袋と封止袋との対向面を一体に接合し、通常時は薬剤収納袋内部を排出口に対して実質的に閉鎖するようにし、輸液の際に薬剤収納袋を外部から加圧することにより惹起される液圧で弱シール部を剥離させて前記複数の隔室を連通させることにより、第1及び第2の隔室の薬剤を混合させ、弱シール部の剥離により惹起される薬剤収納袋の拡開により封止袋を破壊させて混合薬剤を排出口に導くようにすると共に、輸液具を栓体に穿刺することにより輸液作業を開始するようにした輸液方法。   A medicine storage bag formed of a flexible film, a discharge port attached to the medicine storage bag for discharging the drug, a stopper provided in the discharge port, and the inside of the drug storage bag store each drug. The inner surface of the medicine storage bag is welded so that the medicine storage bag is separated and opened by a pressing force applied from the outside to mix the medicine stored in each compartment. A multi-chamber container having a weak seal portion that performs the infusion operation, wherein the discharge port is formed of a flexible film that is weaker than the flexible film constituting the drug storage bag, and stores the drug. A sealing bag that surrounds and closes the open end of the discharge port inside the medicine storage bag is provided inside the bag, and the opposite surfaces of the medicine storage bag and the sealing bag are joined together. Make sure that the inside of the storage bag is substantially closed with respect to the outlet. The medicine in the first and second compartments is mixed by peeling the weak seal portion with the fluid pressure caused by pressurizing the medicine storage bag from the outside and communicating the plurality of compartments. The sealing bag is broken by opening the medicine storage bag caused by the peeling of the seal portion so that the mixed medicine is guided to the discharge port, and the infusion work is started by puncturing the infusion device into the stopper. Infusion method.
JP2007544218A 2005-11-14 2006-11-13 Multi-chamber container Expired - Fee Related JP4962733B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007544218A JP4962733B2 (en) 2005-11-14 2006-11-13 Multi-chamber container

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005328592 2005-11-14
JP2005328592 2005-11-14
JP2007544218A JP4962733B2 (en) 2005-11-14 2006-11-13 Multi-chamber container
PCT/JP2006/322564 WO2007055355A1 (en) 2005-11-14 2006-11-13 Multichamber container

Publications (2)

Publication Number Publication Date
JPWO2007055355A1 true JPWO2007055355A1 (en) 2009-04-30
JP4962733B2 JP4962733B2 (en) 2012-06-27

Family

ID=38023347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544218A Expired - Fee Related JP4962733B2 (en) 2005-11-14 2006-11-13 Multi-chamber container

Country Status (2)

Country Link
JP (1) JP4962733B2 (en)
WO (1) WO2007055355A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5223244B2 (en) * 2007-06-22 2013-06-26 味の素株式会社 Multi-chamber container
WO2009011179A1 (en) 2007-07-17 2009-01-22 Ajinomoto Co., Inc. Double-chamber container
WO2019086251A1 (en) * 2017-11-06 2019-05-09 Calbact Ag Calorimeter and sample container for a calorimeter

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003305107A (en) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc Medicine discharge member and medical double-chamber container
JP2005028040A (en) * 2003-07-11 2005-02-03 Medicalseed:Kk Sealing plug for partition bag
EP1762213B1 (en) * 2004-04-08 2013-07-10 Ajinomoto Co., Inc. Sealedbody containing medicine

Also Published As

Publication number Publication date
WO2007055355A1 (en) 2007-05-18
JP4962733B2 (en) 2012-06-27

Similar Documents

Publication Publication Date Title
JP3316577B2 (en) Peelable seal and container provided with the seal
JP5299640B2 (en) Multi-chamber container
US4961495A (en) Plastic container having an easy-to-peel seal forming compartments
JP4096200B2 (en) Medical multi-chamber container and storage bag for storing the same
JP4993220B2 (en) Multi-chamber container
WO2005115871A1 (en) Sealingly storing bag of multiple compartment structure
JPH05509025A (en) Flexible container and method for forming the same
JP5418649B2 (en) Multi-chamber container
JP5057172B2 (en) Multi-chamber container
JP4962733B2 (en) Multi-chamber container
JP4535840B2 (en) Manufacturing method of medical multi-chamber container
JP2007190161A (en) Double-chamber container
JPWO2010082649A1 (en) Multi-chamber container
JP2007260252A (en) Medical container
JP4822860B2 (en) Medical multi-chamber container
JP2006263375A (en) Container with double chambers for medical use
JP2004208883A (en) Production method of medical container, and medical container
JP4599918B2 (en) Drug storage sealing body and method for forming drug storage sealing body
JP2008061669A (en) Multi-chamber container
JP4412468B2 (en) MEDICAL MIXED CHEMICAL SOLID BODY AND SEALING METHOD
JP2007185418A (en) Multi-chamber container
JP5223244B2 (en) Multi-chamber container
JP3903522B2 (en) Multi-chamber separation container
JP4365948B2 (en) Infusion bag
JP2000262589A (en) Double chamber container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111027

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120229

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120313

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150406

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150406

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees